Another American dose-escalation study is being conducted at the City of Hope Medical Center (Duarte, CA) to investigate the side effects and the best dose of HER2-CAR-T cells in treating patients with BC metastasized to the brain or leptomeninges. The gene discussed is ERBB2; the disease is breast cancer.